semaglutide phase 1 Five Unexpected New Uses for GLP-1 Receptor Agonists GLP-1 Drug Improved Motivation in

GLP-1 GLP-1 6 2020.07.22 GLP-1 SNAC SNACSNAC (1) SNACpH GLP-1DPP-4 GLP-1GLP-1DPP-4 GLP-1GLP-1 GLP-1 PIONEER(PIONNER 1)SGLT-2(PIONEER 2)GLP-1(PIONEER 4)PIONNER 10 PIONEER 1-814mg13.5-kg BMI31-33 PIONEER 9 (2) 123mg, 7mg, 14mg0.9 PIONEER 10 (3) 12 3mg, 7mg, 14mg 0.75/ PIONEER 9 PIONEER 10 PIONEER 9 (2) 7mgHbA1c -1.5% GLP-1 (4) 25.4% 25.4% (10.8%) (4.3%) (4.3%) (2.4%) GLP-1 SU 117mg 113mg4117mg 117mg41114mg 1120ml 50mL240mL(AUC)40 (4) 120mL50mL120mL (4) 30 5(C max )32%(AUC)34 (4) 20201118 (5) 3mg143.20 7mg334.20 14mg501.30 GLP-1 30 (1) Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme

These drugs work by mimicking a hormone (called GLP-1) that helps your body regulate blood sugar and hunger signals

Nine patients died during the study (three in the semaglutide group and six in the placebo group), with no evident clustering of cause of death

Are There Any Side Effects That Affect the Speed of Results

Fabrizio adds

[48] Connolly, H